148 related articles for article (PubMed ID: 22818144)
1. Investigation of a Ca2+ channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial.
Nickel JC; Crossland A; Davis E; Haab F; Mills IW; Rovner E; Scholfield D; Crook T
J Urol; 2012 Sep; 188(3):817-23. PubMed ID: 22818144
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
Bosch PC
J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
[TBL] [Abstract][Full Text] [Related]
3. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
5. Examination of the significant placebo effect in the treatment of interstitial cystitis/bladder pain syndrome.
Bosch PC
Urology; 2014 Aug; 84(2):321-6. PubMed ID: 24958479
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.
Korting GE; Smith SD; Wheeler MA; Weiss RM; Foster HE
J Urol; 1999 Feb; 161(2):558-65. PubMed ID: 9915448
[TBL] [Abstract][Full Text] [Related]
7. Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study.
Wang H; Russell LJ; Kelly KM; Wang S; Thipphawong J
BMC Urol; 2017 Jan; 17(1):2. PubMed ID: 28056917
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Wagg A; Wyndaele JJ; Sieber P
Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
[TBL] [Abstract][Full Text] [Related]
9. The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis.
Nickel JC; Payne CK; Forrest J; Parsons CL; Wan GJ; Xiao X
J Urol; 2009 Jun; 181(6):2555-61. PubMed ID: 19375108
[TBL] [Abstract][Full Text] [Related]
10. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study.
Nickel JC; Herschorn S; Whitmore KE; Forrest JB; Hu P; Friedman AJ; Baseman AS
J Urol; 2015 Mar; 193(3):857-62. PubMed ID: 25245489
[TBL] [Abstract][Full Text] [Related]
11. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
Nitti VW; Dmochowski R; Sand PK; Forst HT; Haag-Molkenteller C; Massow U; Wang J; Brodsky M; Bavendam T
J Urol; 2007 Dec; 178(6):2488-94. PubMed ID: 17937959
[TBL] [Abstract][Full Text] [Related]
13. Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome.
Matsumoto S; Ueda T; Kakizaki H
Urology; 2013 Feb; 81(2):226-30. PubMed ID: 23374763
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial.
van Ophoven A; Rossbach G; Pajonk F; Hertle L
J Urol; 2006 Oct; 176(4 Pt 1):1442-6. PubMed ID: 16952654
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.
van Ophoven A; Pokupic S; Heinecke A; Hertle L
J Urol; 2004 Aug; 172(2):533-6. PubMed ID: 15247722
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.
Mayer R; Propert KJ; Peters KM; Payne CK; Zhang Y; Burks D; Culkin DJ; Diokno A; Hanno P; Landis JR; Madigan R; Messing EM; Nickel JC; Sant GR; Warren J; Wein AJ; Kusek JW; Nyberg LM; Foster HE;
J Urol; 2005 Apr; 173(4):1186-91. PubMed ID: 15758738
[TBL] [Abstract][Full Text] [Related]
19. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
Lai MC; Kuo YC; Kuo HC
Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
[TBL] [Abstract][Full Text] [Related]
20. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
